Catalyst Wire Dossier Catalyst Wire Dossier

gabapentin enacarbil (Horizant)

gabapentin enacarbil · Astellas Pharma Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for gabapentin enacarbil (Horizant), covering 2016-02-04 to 2016-02-04. Get the full timeline:

Most recent: Clinical Trial Update: Long-term Efficacy and Safety of Gabapentin Enacarbil in Japanese Restless Legs Syndrome Patients [Phase 3]

See pricing